Green fluorescent protein as a reporter for retrovirus and helper virus- free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo

NeuroReport

Volumn 8, Issue 17, 1997, Pages 3801-3808

  Aboody Guterman, K S ^a   Pechan, P A ^a   Rainov, N G ^a,d   Sena Esteves, M ^a   Jacobs, A ^a   Snyder, E Y ^b   Wild, P ^c   Schraner, E ^c   Tobler, K ^c,e   Breakefield, X O ^a   Fraefel, C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CNS; Gene transfer; Gliomas; Green fluorescent protein; Helper virus free HSV 1 amplicon vector; Neural progenitor cells; Retrovirus vector

Indexed keywords

GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; FLUORESCENCE ACTIVATED CELL SORTER; GENE TRANSFER; GLIOMA; HELPER CELL; HERPES SIMPLEX VIRUS; MARKER GENE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; RETROVIRUS; STEM CELL; TRANSGENE;

EID: 15444351633     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712010-00029     Document Type: Article

References (25)

1. Chalfie M et al. Science 263, 802-805 (1994).
2. Prasher DC et al. Gene 111, 229-233 (1992).
3. Cepko C. Neuron 1, 345-353 (1988).
4. Sena-Esteves M et al. Gene delivery to the nervous system using retroviral vectors. In: Latchman D. (ed.). Genetic Manipulation of the Nervous System. New York: Academic Press, 1995: 149-180.
5. Glorioso JC et al. Herpes simplex virus as a gene delivery vector for the central nervous system In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. San Diego: Academic Press, 1995: 1-23.
6. Kwong AD, Frenkel N. Biology of herpes simplex virus (HSV) defective viruses and development of the amplicon system. In: Kaplitt MG, Loewy AD (eds). Viral Vectors: Gene Therapy and Neuroscience Applications. San Diego: Academic Press, 1995: 25-42.
7. Fraefel C, Breakefield XO, Jacoby D. The HSV-1 amplicon. In: Chiocca EA, Breakefield XO (eds). Gene Therapy of Neurological Disorders. Totowa: Humana Press.
8. Fraefel C et al. J Virol 70, 7190-7197 (1996).
9. Moriyoshi K et al. Neuron 16, 255-260 (1996).
10. Peel AL et al. Gene Therapy 4, 16-24 (1997).
11. Naldini L et al. Proc Natl Acad Sci USA 93, 11382-11388 (1996).
12. Pear WS, Nolan GP, Scott ML, Baltimore D. Proc Natl Acad Sci USA 90, 8392-8396 (1993).
13. Ko L, Koestner A, Wechsler W. Acta Neuropath 51, 23-34 (1980).
14. Weizsaecker M et al. J Neurol 224, 183-192 (1981).
15. Kruse et al. J Neuro-Oncology 22, 191-200 (1994).
16. Snyder EY et al. Cell 68, 33-51 (1992).
17. Smith IL, Hardwicke MA, Sandri-Goldin RM. Virology 186, 74-86 (1992).
18. Konradi C, Leveque J-C, Hyman SE. J Neurosci 16, 4231-4239 (1996).
19. Ghattas IR, Sanes JR, Majors JE. Mol Cell Biol 11, 5848-5859 (1991).
20. Morgenstern JP, Land H. Nucleic Acids Res 18, 1068 (1990).
21. Cunningham C, Davison AJ. Virology 197, 116-124 (1993).
22. Lim F et al. Biotechniques 20, 460-469 (1996).
23. Heim R, Cubitt AB, Tsien RY. Nature 273, 663-664 (1995).
24. Haas J, Park EC, Seed B. Curr Biol 6, 315-324 (1996)
25. Mosser DD et al. Biotechniques 22, 150-161 (1997).